metastatic breast cancer
Conditions
Interventions
None listed
Sponsors
FACO (Federation of Asian Clinical Oncology)
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1 recurrent case performed by curative operation 2 oligometastatic breast cancer defined as in the protocol 3 oligometastatic breast cancer diagnosed between 2005 and 2012 4 systemic therapy or locoregional and systemic therapy performed 5 the order of locoregional therapy and systemic therapy is decided at the physicians discretion
Exclusion criteria
Exclusion criteria: 1 recurrent case with any kind of pleural effusion 2 recurrent case with any kind of ascites beyond a physiological condition 3 recurrent case with any kind of pericardiac effusion 4 recurrent case with a non-curative operation of primary breast cancer, except for cases with a positive surgical margin with noninvasive cancer or cases of sentinel lymph nodes with isolated tumor cells or micrometastases in which axillary lymph node dissection was not performed 5 recurrent case of ipsilateral breast tumor 6 recurrent case with no pathological confirmation of primary breast cancer 7 recurrent case with a past history of other invasive cancer 8 recurrent case with severe or life threatening comorbidity due to myocardial infarction, cerebral infarction, diabetes mellitus, autoimmune disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary endpoint is the estimated 5-year OS after the initial diagnosis of oligometastatic BC. | — |
Countries
Japan,Asia(except Japan)
Contacts
Public ContactMami Sakurai
FACO (Federation of Asian Clinical Oncology) Office
Outcome results
None listed